Eric Drape - 16 Feb 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Signature
/s/ Dov Bergwerk as attorney-in-fact for Eric Drape
Issuer symbol
TEVA
Transactions as of
16 Feb 2024
Net transactions value
-$2,261,905
Form type
4
Filing time
21 Feb 2024, 07:37:43 UTC
Previous filing
01 Feb 2024
Next filing
01 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Sale $2,261,905 -173,261 -100% $13.05 1 16 Feb 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.15, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Number of shares rounded to the nearest whole share.